COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

15/11/2018 - 14:36

Bagsværd, Denmark, 15 November 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

TRACON Pharmaceuticals Presents New Circulating Tumor Cell Data from Ongoing Pivotal Phase 3 TAPPAS Trial of TRC105 and Votrient® in Patients with Angiosarcoma

15/11/2018 - 14:35

Changes in Endoglin Expressing Circulating Tumor Cells (CTC) Detected in Phase 3 TAPPAS Trial Changes in CTC count may be useful as a prognostic biomarker and baseline CTC may be useful as a predictive biomarker SAN [...]

Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 2018

15/11/2018 - 14:30

Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone and KOL discussion of [...]

Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting

15/11/2018 - 14:30

Company Reviews Mechanism of Action, Preclinical Outcomes and Phase 1 Safety Results of VX15 (pepinemab) as Single Agent and In Combination Therapy Against Multiple Cancers ROCHESTER, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE [...]

Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference

15/11/2018 - 14:30

SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber, Ph.D., [...]

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

15/11/2018 - 14:30

Increases in Revenues and Profit Margins Net Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO [...]

Align Technology Ongoing Support of Orthodontic and Dental Research

15/11/2018 - 14:30

2019 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2019 Research Award [...]

Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018

15/11/2018 - 14:05

DCCR treatment resulted in statistically significant decreases in body fat in subjects with Prader-Willi Syndrome REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a [...]

Inovio Prepares for Growth & Commercialization With Leadership Appointments

15/11/2018 - 14:00

Prominent immunologist joins Scientific Advisory Board R&D leader appointed Chief Scientific Officer Industry veteran appointed Vice President, Commercial PLYMOUTH MEETING, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- [...]

Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018

15/11/2018 - 14:00

Company continues on track to initiate combined Phase 3 clinical trial in Alström Syndrome and Bardet-Biedl Syndrome before end of 2018 BOSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM [...]

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results

15/11/2018 - 14:00

REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies

15/11/2018 - 14:00

Event to be webcast live at 12 pm ET CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, announced [...]

SPR Therapeutics Announces First Use of SPRINT endura Peripheral Nerve Stimulation System to treat Complex Regional Pain Syndrome

15/11/2018 - 14:00

SPRINT System is the least invasive PNS device for CRPS CLEVELAND, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Marc Huntoon [...]

Maverick Technology Solutions’ ROSINBOMB™ ROCKET is Now Patent Pending

15/11/2018 - 14:00

Company Files its Second Patent Application with the US Patent and Trademark Office for its innovative consumer extraction press. RENO, Nev., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC: MVRK ) [...]

Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference

15/11/2018 - 14:00

MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]

Big Health to Offer Better Sleep Program for BJC HealthCare Employees

15/11/2018 - 14:00

Missouri Health System Adds Digital Sleep Improvement Program, Sleepio, to Employee Benefits SAN FRANCISCO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Big Health , a digital medicine company dedicated to getting millions back to [...]

Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing

15/11/2018 - 14:00

MIAMI, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending Sept. 30, 2018, as well [...]

New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments

15/11/2018 - 14:00

Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development [...]

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2018 Financial Results

15/11/2018 - 13:30

Conference call today at 8:00 a.m. ET NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]